Q-omics provides the consensus-scored KRTAP21-3 profile across patient tissues and cancer cell-line models. KRTAP21-3 expression is associated with patient survival in 8 of 34 cancer types, with the highest sampling consensus in LIHC. Additionally, KRTAP21-3 RNA expression shows 6,709 significant gene co-expression associations, with the highest sampling consensus in UCEC. Together, these results highlight LIHC, and UCEC as cancer lineages where KRTAP21-3 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for KRTAP21-3 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes KRTAP21-3 survival associations across molecular data types. KRTAP21-3 RNA expression shows survival associations in the most cancer types (8). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible KRTAP21-3 RNA expression–survival associations across cancer types. High KRTAP21-3 expression shows unfavorable associations in LIHC, BLCA, READ, COAD and LGG, but favorable associations in ESCA. The LIHC Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify LIHC as the clearest survival context for KRTAP21-3 RNA expression.
This table shows molecular features associated with KRTAP21-3 in patient tissues and cancer cell lines. In patient samples, KRTAP21-3 shows the broadest associations at the RNA and protein expression levels, with UCEC recurring as the lineage with the largest associated feature set. In cancer cell lines, KRTAP21-3 RNA and mutation anchors are most strongly linked to RNA-expression features, especially in SKIN, while CRISPR and shRNA rows add functional-dependency signals in KIDNEY and STOMACH.
